Teladoc Health: This 'Expanding' Company Is A Long-Term Buy
- Teladoc Health recently announced that it entered into an agreement to acquire a European telemedicine provider and that it had plans to expand into Canada.
- The stock is not cheap, but I do not believe that Teladoc's growth prospects are fully baked into the price.
- I am long Teladoc Health, and I plan to stay long the stock.
Teladoc Health's ($TDOC) stock has underperformed the broader market so far in 2019, but shares have significantly outperformed the S&P 500 ($SPY) over the last year.
There are plenty of reasons to like Teladoc in today's environment - read this latest article for my thoughts on the company's bull case - but I believe that the recent announcements related to management's expansion plans should get investors even more excited about what the future may hold for this growing, disruptive company.
Read more here.